These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23733872)

  • 21. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
    Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
    Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control of memory CD8+ T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response.
    Fuse S; Zhang W; Usherwood EJ
    J Immunol; 2008 Jan; 180(2):1148-57. PubMed ID: 18178855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated CD8+ T-effector/memory cells eliminate CD4+ CD25+ Foxp3+ T-suppressor cells from tumors via FasL mediated apoptosis.
    Kilinc MO; Rowswell-Turner RB; Gu T; Virtuoso LP; Egilmez NK
    J Immunol; 2009 Dec; 183(12):7656-60. PubMed ID: 19923444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human herpesvirus-6-specific interleukin 10-producing CD4+ T cells suppress the CD4+ T-cell response in infected individuals.
    Wang F; Yao K; Yin QZ; Zhou F; Ding CL; Peng GY; Xu J; Chen Y; Feng DJ; Ma CL; Xu WR
    Microbiol Immunol; 2006; 50(10):787-803. PubMed ID: 17053315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection.
    Sparks-Thissen RL; Braaten DC; Kreher S; Speck SH; Virgin HW
    J Virol; 2004 Jul; 78(13):6827-35. PubMed ID: 15194758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perforin and Fas in murine gammaherpesvirus-specific CD8(+) T cell control and morbidity.
    Topham DJ; Cardin RC; Christensen JP; Brooks JW; Belz GT; Doherty PC
    J Gen Virol; 2001 Aug; 82(Pt 8):1971-1981. PubMed ID: 11458005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD8+ dendritic cell-mediated tolerance of autoreactive CD4+ T cells is deficient in NOD mice and can be corrected by blocking CD40L.
    Price JD; Beauchamp NM; Rahir G; Zhao Y; Rieger CC; Lau-Kilby AW; Tarbell KV
    J Leukoc Biol; 2014 Feb; 95(2):325-36. PubMed ID: 24082013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4(+) T-cell dependence of primary CD8(+) T-cell response against vaccinia virus depends upon route of infection and viral dose.
    Hu Z; Molloy MJ; Usherwood EJ
    Cell Mol Immunol; 2016 Jan; 13(1):82-93. PubMed ID: 25544501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope.
    Stevenson PG; Belz GT; Castrucci MR; Altman JD; Doherty PC
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9281-6. PubMed ID: 10430934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4+ CD25+ Foxp3- T-regulatory cells produce both gamma interferon and interleukin-10 during acute severe murine spotted fever rickettsiosis.
    Fang R; Ismail N; Shelite T; Walker DH
    Infect Immun; 2009 Sep; 77(9):3838-49. PubMed ID: 19564386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of a distinct HIV-specific IL-10-producing CD8+ T-cell subset with immunomodulatory functions during chronic HIV-1 infection.
    Clutton G; Yang H; Hancock G; Sande N; Holloway C; Angus B; von Delft A; Barnes E; Borrow P; Pellegrino P; Williams I; McMichael A; Dorrell L
    Eur J Immunol; 2013 Nov; 43(11):2875-85. PubMed ID: 23897063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural history of murine gamma-herpesvirus infection.
    Nash AA; Dutia BM; Stewart JP; Davison AJ
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):569-79. PubMed ID: 11313012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.
    Boettler T; Spangenberg HC; Neumann-Haefelin C; Panther E; Urbani S; Ferrari C; Blum HE; von Weizsäcker F; Thimme R
    J Virol; 2005 Jun; 79(12):7860-7. PubMed ID: 15919940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insights into CD8 T Cell Activation and Exhaustion from a Mouse Gammaherpesvirus Model.
    Sarawar SR; Shen J; Dias P
    Viral Immunol; 2020 Apr; 33(3):215-224. PubMed ID: 32286179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-15 induces type 1 and type 2 CD4+ and CD8+ T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12 / IL-4 stimulation in vitro.
    Niedbala W; Wei X; Liew FY
    Eur J Immunol; 2002 Feb; 32(2):341-7. PubMed ID: 11807773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different functional capacities of latent and lytic antigen-specific CD8 T cells in murine gammaherpesvirus infection.
    Obar JJ; Crist SG; Gondek DC; Usherwood EJ
    J Immunol; 2004 Jan; 172(2):1213-9. PubMed ID: 14707099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tregs Modulate Lymphocyte Proliferation, Activation, and Resident-Memory T-Cell Accumulation within the Brain during MCMV Infection.
    Prasad S; Hu S; Sheng WS; Singh A; Lokensgard JR
    PLoS One; 2015; 10(12):e0145457. PubMed ID: 26720146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.
    Dobrzanski MJ; Reome JB; Dutton RW
    J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depletion of CD4+ T cells precipitates immunopathology in immunodeficient mice infected with a noncytocidal virus.
    Christensen JP; Bartholdy C; Wodarz D; Thomsen AR
    J Immunol; 2001 Mar; 166(5):3384-91. PubMed ID: 11207295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic immune therapy induces a progressive increase in intratumoral T suppressor activity and a concurrent loss of tumor-specific CD8+ T effectors in her-2/neu transgenic mice bearing advanced spontaneous tumors.
    Nair RE; Kilinc MO; Jones SA; Egilmez NK
    J Immunol; 2006 Jun; 176(12):7325-34. PubMed ID: 16751376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.